ReviewFrontiers in pharmacology2026
HtrA2/Omi: potential therapeutic targets for neurodegenerative diseases.
Liting Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ReviewFrontiers in pharmacology2026
Liting Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.